Latest cancer research and care | Chris O'Brien Lifehouse

Posted Mon April 12, 2021

PH News featured the superior surgical outcomes of Chris O’Brien Lifehouse from Cancer Institute NSW data.
Senior Lecturer and Lifehouse patient, Siobhan O’Sullivan, shared her personal story of ovarian cancer and encourages women to know the signs and see their doctor if they have any concerns.
Prof Michael Boyer AM commended Cancer Aid’s partnership with insurance company Aon to support employees diagnosed with cancer and those providing cancer care for family members.
A grateful patient called into Richard Glover’s show on Friday 12 February to highlight the care they received, inspiring Richard to share his praises of Chris O’Brien Lifehouse.
A/Prof Sanjay Warrier appeared on Healthy Living with Dr Ross Walker on Radio 2GB talking about cancer and breast implants on 17 January.
CEO Eileen Hannagan was named as one of Inner West’s top businesswomen. She shared insights into her success with the Inner West Courier.
A/Prof Carsten Palme highlighted the importance of early detection and treatment at high volume expert centres to increase the chance of surviving oral cancer caused by HPV in The Australian.

Chief Clinical Officer, Prof. Michael Boyer AM, was invited to present his findings in the Presidential Symposium at the Lung Cancer World Conference in 2020, a showcase of the leading lung cancer research in the world. His study found that the combination of two immunotherapy drugs, ipilimumab and pembrolizumab is not effective for a particular group of patients with metastatic non-small cell lung cancer (NSCLC) “The addition of ipilimumab did not improve overall or progression-free survival”, Prof. Boyer explained. The study confirmed pembrolizumab monotherapy to remain a first-line standard of care for this group of patients.
Medical oncologist Steven Kao was interviewed for Asbestos.com about criteria for mesothelioma clinical trials and why they need to be more inclusive.
Prof. Jonathan Clark AM and a team of researchers received a $3.75m grant from Cancer Institute NSW to lessen the impact of head and neck surgery.
Chris O’Brien Lifehouse clinical trial partner Tilray received approval to expand medicinal cannabis in New Zealand.

SurFebruary co-founder, Jenna-Lea Clark appeared on Deborah Knight on 2GB on 4 Feb to share her story of overcoming cancer and encourage people to get on board to raise funds for cancer research at Chris O’Brien Lifehouse.
Jenna-Lea Clark was featured on NBN news and online to share excitement about the growth of SurFebruary.
Studio 10 Daniel Doody hit the waves with the SurFebruary founders to get people excited about the fundraiser for cancer research at Chris O’Brien Lifehouse. Check out the live cross on Friday 5 Feb.